Tocilizumab for systemic juvenile idiopathic arthritis

Comment

Noboru Hagino et al. N Engl J Med. 2013.

. 2013 Mar 28;368(13):1256.

doi: 10.1056/NEJMc1301017.

No abstract available

Comment in

Tocilizumab for systemic juvenile idiopathic arthritis.
De Benedetti F. De Benedetti F. N Engl J Med. 2013 Mar 28;368(13):1256-7. doi: 10.1056/NEJMc1301017. N Engl J Med. 2013. PMID: 23534566 No abstract available.

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.
De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A; PRINTO; PRCSG. De Benedetti F, et al. N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802. N Engl J Med. 2012. PMID: 23252525 Clinical Trial.